Annual EBITDA
$666.60M$42.50M+6.81%
Summary
- Current Value
- As of today, NBIX annual EBITDA is $666.60M, up +6.81% on
- Historical Performance
- NBIX annual EBITDA is up +150.32% over the past 3 years, up +98.33% over the past 5 years
- All-Time High Comparison
- NBIX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- NBIX annual EBITDA is +150.32% above its 3-year low of $266.30M reached on an earlier date
- Sector Comparison
- NBIX annual EBITDA is higher than 91.77% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $666.60M | +6.8% | +150.3% | +98.3% | +7126.5% | |
| Quarterly EBITDA | $235.40M | +54.8% | +115.0% | +218.1% | +9048.9% | |
| TTM EBITDA | $666.60M | +9.3% | +150.3% | +98.3% | +7126.5% | |
| Price | $128.13 | +13.7% | +27.2% | +37.4% | +1746.3% | |
| PE Ratio | 27.45 | -19.8% | -58.0% | +22.4% | – | |
| Annual Revenue | $2.86B | +21.4% | +92.2% | +173.5% | +8438.5% | |
| Annual EPS | $4.67 | +41.9% | +198.9% | +12.1% | +3212.9% | |
| $636.50M | +6.6% | +153.9% | +94.3% | +5927.1% | ||
| Annual Net Income | $478.60M | +40.2% | +209.8% | +17.5% | +6106.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $666.60M | at high | |
| 5Y | $666.60M | at high | |
| All | $666.60M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $266.30M | N/A | +150.3% |
| 5Y | $218.70M | +204.8% | |
| All | -$145.87M | +557.0% |
EBITDA History
FAQ
What is the current annual EBITDA of NBIX?
As of today, NBIX annual EBITDA is $666.60M
What is 1-year change in NBIX annual EBITDA?
NBIX annual EBITDA is up +6.81% year-over-year
What is 3-year change in NBIX annual EBITDA?
NBIX annual EBITDA is up +150.32% over the past 3 years
How far is NBIX annual EBITDA from its all-time high?
NBIX annual EBITDA is currently at its all-time high
How does NBIX annual EBITDA rank versus sector peers?
NBIX annual EBITDA is higher than 91.77% of companies in Healthcare sector
When is NBIX next annual earnings release?
As of today, the next annual earnings release for NBIX has not been scheduled
Quarterly EBITDA
$235.40M$11.60M-4.70%
Summary
- Current Value
- As of today, NBIX quarterly EBITDA is $235.40M, down -4.70% on
- Historical Performance
- NBIX quarterly EBITDA is up +54.77% year-over-year, up +114.98% over the past 3 years
- All-Time High Comparison
- NBIX quarterly EBITDA is currently -4.70% below its historical high of $247.00M set on
- 3-Year Low Comparison
- NBIX quarterly EBITDA is +652.08% above its 3-year low of $31.30M reached on
- Sector Comparison
- NBIX quarterly EBITDA is higher than 92.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $235.40M | -4.7% | +54.8% | +115.0% | +218.1% | |
| Annual EBITDA | $666.60M | – | +6.8% | +150.3% | +98.3% | |
| TTM EBITDA | $666.60M | +14.3% | +9.3% | +150.3% | +98.3% | |
| Price | $128.13 | -17.6% | +13.7% | +27.2% | +37.4% | |
| PE Ratio | 27.45 | -26.1% | -19.8% | -58.0% | +22.4% | |
| Quarterly Revenue | $805.50M | +1.3% | +28.3% | +95.5% | +224.9% | |
| Quarterly EPS | $1.48 | -27.5% | +47.9% | +67.9% | -58.6% | |
| $227.90M | -4.8% | +57.2% | +116.8% | +217.4% | ||
| Quarterly Net Income | $153.70M | -26.6% | +49.1% | +72.7% | -55.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $247.00M | -4.7% | |
| 3Y | $247.00M | -4.7% | |
| 5Y | $247.00M | -4.7% | |
| All | $247.00M | -4.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $31.30M | +652.1% | |
| 3Y | $31.30M | +652.1% | |
| 5Y | $6.40M | +3578.1% | |
| All | -$79.44M | +396.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NBIX?
As of today, NBIX quarterly EBITDA is $235.40M
What is NBIX quarterly EBITDA most recent change?
NBIX quarterly EBITDA was down -4.70% on December 31, 2025
What is 1-year change in NBIX quarterly EBITDA?
NBIX quarterly EBITDA is up +54.77% year-over-year
How far is NBIX quarterly EBITDA from its all-time high?
NBIX quarterly EBITDA is currently -4.70% below its historical high of $247.00M set on September 30, 2025
How does NBIX quarterly EBITDA rank versus sector peers?
NBIX quarterly EBITDA is higher than 92.25% of companies in Healthcare sector
When is NBIX next earnings release?
The next earnings release for NBIX is on
TTM EBITDA
$666.60M$83.30M+14.28%
Summary
- Current Value
- As of today, NBIX TTM EBITDA is $666.60M, up +14.28% on
- Historical Performance
- NBIX TTM EBITDA is up +9.26% year-over-year, up +150.32% over the past 3 years
- All-Time High Comparison
- NBIX TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- NBIX TTM EBITDA is +150.32% above its 3-year low of $266.30M reached on an earlier date
- Sector Comparison
- NBIX TTM EBITDA is higher than 91.52% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $666.60M | +14.3% | +9.3% | +150.3% | +98.3% | |
| Annual EBITDA | $666.60M | – | +6.8% | +150.3% | +98.3% | |
| Quarterly EBITDA | $235.40M | -4.7% | +54.8% | +115.0% | +218.1% | |
| Price | $128.13 | -17.6% | +13.7% | +27.2% | +37.4% | |
| PE Ratio | 27.45 | -26.1% | -19.8% | -58.0% | +22.4% | |
| TTM Revenue | $2.86B | +6.6% | +21.4% | +92.2% | +173.5% | |
| TTM EPS | $4.67 | +11.5% | +41.8% | +203.0% | +12.3% | |
| $636.50M | +15.0% | +9.2% | +153.9% | +94.3% | ||
| TTM Net Income | $478.60M | +11.8% | +40.2% | +209.8% | +17.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $666.60M | at high | |
| 3Y | $666.60M | at high | |
| 5Y | $666.60M | at high | |
| All | $666.60M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $527.60M | +26.4% | |
| 3Y | $266.30M | N/A | +150.3% |
| 5Y | $179.30M | +271.8% | |
| All | -$219.91M | +403.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NBIX?
As of today, NBIX TTM EBITDA is $666.60M
What is NBIX TTM EBITDA most recent change?
NBIX TTM EBITDA was up +14.28% on December 31, 2025
What is 1-year change in NBIX TTM EBITDA?
NBIX TTM EBITDA is up +9.26% year-over-year
How far is NBIX TTM EBITDA from its all-time high?
NBIX TTM EBITDA is currently at its all-time high
How does NBIX TTM EBITDA rank versus sector peers?
NBIX TTM EBITDA is higher than 91.52% of companies in Healthcare sector
When is NBIX next earnings release?
The next earnings release for NBIX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- NBIX Official Website www.neurocrine.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447526000007/0000914475-26-000007-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447526000007/0000914475-26-000007-index.htm
- NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
- NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix